Cargando…

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

BACKGROUND: Diarrhea-predominant irritable bowel syndrome (IBS-d) significantly diminishes the health-related quality of life (HRQOL) of patients. Psychological and social impacts are common with many IBS-d patients reporting comorbid depression, anxiety, decreased intimacy, and lost working days. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrae, David A, Patrick, Donald L, Drossman, Douglas A, Covington, Paul S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895767/ https://www.ncbi.nlm.nih.gov/pubmed/24330412 http://dx.doi.org/10.1186/1477-7525-11-208

Ejemplares similares

Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)
por: Kanazawa, Motoyori, et al.
Publicado: (2007)

Contemporary diagnosis and management of irritable bowel syndrome /
por: Drossman, Douglas A.
Publicado: (2002)

Biopsychosocial Model of Irritable Bowel Syndrome
por: Tanaka, Yukari, et al.
Publicado: (2011)

Validity, reliability, and factor analysis of Persian version of quality of life questionnaire for irritable bowel syndrome (IBS-QOL-34)
por: Masaeli, Nasrine, et al.
Publicado: (2013)

The role of inflammation in irritable bowel syndrome (IBS)
por: Ng, Qin Xiang, et al.
Publicado: (2018)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

Anti-Enteric Neuronal Antibodies and the Irritable Bowel Syndrome
por: Wood, Jackie D, et al.
Publicado: (2012)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Health Related Quality of Life in Iranian Patients With Irritable Bowel Syndrome: Reliability and Validity of the Persian Version of the IBS-QOL
por: Jafari, Peyman, et al.
Publicado: (2013)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
por: Seretis, C., et al.
Publicado: (2011)

Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome
por: Chen, Qian, et al.
Publicado: (2023)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial
por: Qi, Ling-Yu, et al.
Publicado: (2021)

Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ)
por: Ebrahimi, Amrollah, et al.
Publicado: (2023)

Correction: Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial
por: Qi, Ling-Yu, et al.
Publicado: (2023)

Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI
por: Zhang, Yanli, et al.
Publicado: (2023)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
por: Kanazawa, Motoyori, et al.
Publicado: (2015)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS
por: Sarvepalli, Sai Suseel, et al.
Publicado: (2023)

Irritable bowel syndrome (IBS) among Lebanese adults: unidentified IBS and associated factors
por: Yazbeck, Gabriella, et al.
Publicado: (2023)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
por: Altomare, Annamaria, et al.
Publicado: (2021)

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
por: Di Rosa, Claudia, et al.
Publicado: (2023)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2020)

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
por: Layer, Peter, et al.
Publicado: (2007)

Use of GELSECTAN(®) in Patients with Irritable Bowel Syndrome (IBS): an Italian Experience
por: Bellini, Massimo, et al.
Publicado: (2021)

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
por: Fang, Xiu-Cai, et al.
Publicado: (2022)

The neurobiology of irritable bowel syndrome
por: Mayer, Emeran A., et al.
Publicado: (2023)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
por: Li, Pingping, et al.
Publicado: (2020)

Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
por: Mourey, Florian, et al.
Publicado: (2022)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
por: Chey, W. D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s946r4tpm74t7fii2tf1u3gu0s